The Claim
Omega-3 supplementation at a dose of 3.6 g/day of EPA and DHA has no significant effect on plasma levels of leukotriene B4, IL-6, IL-1β, TNF-α, TGF-β, or other tested cytokines in heavy smokers, while its anti-inflammatory effects are limited to CRP and PGE2.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 3.6 grams of omega-3 fatty acids daily does not lower levels of several inflammatory markers in the blood of heavy smokers, but it does reduce two specific markers: CRP and PGE2.
See the scientific wording
Omega-3 supplementation (3.6 g/day EPA+DHA) does not significantly reduce plasma levels of leukotriene B4, IL-6, IL-1β, TNF-α, TGF-β, or other tested cytokines in heavy smokers, indicating its anti-inflammatory effects are selective for CRP and PGE2.
Omega-3 fats replace other fats in cell membranes, which reduces the production of a specific inflammatory chemical called PGE2. Lower PGE2 leads to less signaling to the liver, which then makes less of another inflammatory marker called CRP. This process does not affect other inflammatory chemicals like leukotriene B4 or cytokines such as IL-6, IL-1β, TNF-α, or TGF-β.
What the research says
1 studyTaking a high dose of omega-3 pills for six months lowered two key inflammation markers (CRP and PGE2) in smokers, but didn’t lower another one (LTB4), which means it doesn’t affect all inflammation markers the same way — just some. This matches the claim that omega-3’s effects are selective.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.